Physician profile
Stephen Johnson
NPI 1699828400
$893.12
in general payments reported to CMS, 2019-2025
13 companies · $69.82 in 2025
The $69.82 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $120 · 2021: $99.96 · 2022: $251 · 2023: $181 · 2024: $57.48 · 2025: $69.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $446.89 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $171.61 | 2019-2023 | Bard Urinary Drainage Bag |
| Ethicon US, LLC | $53.61 | 2022-2024 | Harmonic, Echelon; Endopath |
| Karl Storz Endoscopy-America | $40.14 | 2021 | |
| Boston Scientific Corporation | $36.90 | 2019-2023 | Rezum Generator |
| Immunitybio, INC. | $31.00 | 2025 | |
| Ambu INC. | $24.59 | 2024 | |
| Laborie Medical Technologies Corp. | $23.82 | 2025 | |
| Astellas Pharma US INC | $19.82 | 2019 | |
| Medtronic, INC. | $15.00 | 2025 | Interstim |
| Antares Pharma, INC. | $14.18 | 2023 | Nocdurna, Tlando, Xyosted |
| Teleflex LLC | $13.07 | 2023 | Urolift |
| Travere Therapeutics, INC. | $2.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.